Kyu-Tae Kim

Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer

W. Park, Kyoung-Mee Kim, Jeeyun Lee, 2022, Journal for ImmunoTherapy of Cancer.

Combination of novel HER2‐targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2‐positive gastric cancer

M. Uhlén, Johan Rockberg, H. Persson, 2015, Molecular oncology.

Bispecific Antibody Molecule Inhibits Tumor Cell Proliferation More Efficiently Than the Two-Molecule Combination

Fredrik Y Frejd, Johan Rockberg, F. Frejd, 2021, Drugs in R&D.

Affibody molecules as engineered protein drugs

Fredrik Y Frejd, F. Frejd, Kyu-Tae Kim, 2017, Experimental &Molecular Medicine.

Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer

Mitchell Ho, Lei Cui, Soyoung Choi, 2015, PloS one.